MARKET

NEOS

NEOS

Neos
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.390
-0.030
-2.11%
Closed 16:00 10/18 EDT
OPEN
1.430
PREV CLOSE
1.420
HIGH
1.430
LOW
1.380
VOLUME
157.00K
TURNOVER
--
52 WEEK HIGH
4.370
52 WEEK LOW
1.130
MARKET CAP
69.13M
P/E (TTM)
-1.5760
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NEOS and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NEOS News

  • Neos Therapeutics (NEOS) Investor Presentation - Slideshow
  • Seeking Alpha - Article.10/03 21:26
  • Neos Therapeutics 8-K Shows Loan, Security Deal With Neos Therapeutics Brands, PharmaFab Texas For Extension Of Up To $25M Secured Revolving Loans
  • Benzinga.10/03 10:20
  • Neos Therapeutics: ADHD Franchise Needs To Return To Prescription Growth
  • Seeking Alpha - Article.09/30 18:09
  • Neos Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference
  • GlobeNewswire.09/25 13:00

More

Industry

Pharmaceuticals
-0.90%
Pharmaceuticals & Medical Research
-0.94%

Hot Stocks

Name
Price
%Change

About NEOS

Neos Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. Its segment is engaged in the development, manufacturing and commercialization of pharmaceuticals. It has utilized its platform to develop its product for the treatment of attention deficit hyperactivity disorder (ADHD). Its product candidates are extended-release (XR), medications in patient-friendly, orally disintegrating tablets (ODT) or liquid suspension dosage forms. Its branded product and product candidates incorporate over two of the prescribed medications for the treatment of ADHD, methylphenidate and amphetamine. Its modified-release drug delivery platform has enabled it to create extended-release ODT and liquid suspension dosage forms of the medications. It focuses on developing Adzenys XR-ODT, Cotempla XR-ODT and NT-0201.
More

Webull offers Neos Therapeutics Inc (NEOS) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.